MUSCATELLO, Maria Rosaria Anna
 Distribuzione geografica
Continente #
EU - Europa 13.069
NA - Nord America 10.703
AS - Asia 6.030
SA - Sud America 2.356
AF - Africa 178
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 11
Totale 32.379
Nazione #
US - Stati Uniti d'America 10.467
RU - Federazione Russa 3.495
IT - Italia 2.703
SG - Singapore 2.569
BR - Brasile 2.068
IE - Irlanda 1.988
SE - Svezia 1.711
CN - Cina 1.676
HK - Hong Kong 781
DE - Germania 758
UA - Ucraina 470
PL - Polonia 441
FI - Finlandia 391
FR - Francia 367
VN - Vietnam 308
GB - Regno Unito 301
IN - India 140
CA - Canada 101
AR - Argentina 92
MX - Messico 91
NL - Olanda 78
TR - Turchia 76
ES - Italia 70
BD - Bangladesh 64
AT - Austria 60
BE - Belgio 56
ID - Indonesia 50
JP - Giappone 50
EC - Ecuador 49
IQ - Iraq 49
ZA - Sudafrica 42
UZ - Uzbekistan 39
CZ - Repubblica Ceca 37
EG - Egitto 37
MA - Marocco 32
CO - Colombia 30
PK - Pakistan 28
PE - Perù 26
VE - Venezuela 26
AU - Australia 25
PH - Filippine 24
CH - Svizzera 23
PY - Paraguay 23
CL - Cile 22
LT - Lituania 21
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
CI - Costa d'Avorio 14
KE - Kenya 14
NP - Nepal 14
PT - Portogallo 14
JO - Giordania 13
BY - Bielorussia 12
IL - Israele 12
TN - Tunisia 12
DZ - Algeria 11
GR - Grecia 11
KZ - Kazakistan 11
BG - Bulgaria 9
DO - Repubblica Dominicana 9
GE - Georgia 9
IR - Iran 9
LV - Lettonia 9
UY - Uruguay 9
AL - Albania 8
KG - Kirghizistan 8
OM - Oman 8
PA - Panama 8
BO - Bolivia 7
NZ - Nuova Zelanda 7
RO - Romania 7
HR - Croazia 6
JM - Giamaica 6
MY - Malesia 6
SN - Senegal 6
AM - Armenia 5
BN - Brunei Darussalam 5
CR - Costa Rica 5
EU - Europa 5
KR - Corea 5
LB - Libano 5
SA - Arabia Saudita 5
SI - Slovenia 5
BH - Bahrain 4
HN - Honduras 4
LK - Sri Lanka 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GY - Guiana 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
CG - Congo 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
Totale 32.349
Città #
Dublin 1.987
Moscow 1.765
Chandler 1.346
Dallas 1.301
Singapore 1.297
Ashburn 1.195
Jacksonville 979
Nyköping 868
Hong Kong 772
Beijing 749
Warsaw 422
Los Angeles 292
Princeton 292
Medford 281
Messina 251
Dearborn 249
Cambridge 240
Rome 231
The Dalles 228
Des Moines 218
Munich 192
New York 184
Boardman 174
Ann Arbor 172
São Paulo 164
Milan 144
Bremen 140
Buffalo 128
Redondo Beach 104
Turku 97
Ho Chi Minh City 91
Houston 91
Catania 85
Jinan 80
Rio de Janeiro 66
Wilmington 66
Tianjin 65
Hanoi 63
Shenyang 62
Lancaster 61
Belo Horizonte 58
Brussels 53
Frankfurt am Main 52
Woodbridge 49
Strasbourg 48
Helsinki 47
Turin 47
Hebei 46
Hyderabad 45
San Mateo 45
Vienna 45
Brasília 43
Seattle 43
Nanjing 42
Tokyo 40
Brooklyn 39
Naples 39
Tashkent 38
Pune 36
Santa Clara 36
London 35
Padova 35
Palermo 35
Stockholm 34
Bari 33
Dong Ket 33
Guangzhou 32
San Francisco 31
Ningbo 30
Udine 30
Zhengzhou 29
Cairo 28
Chicago 28
Jakarta 28
Mexico City 28
Montreal 28
Porto Alegre 28
Curitiba 27
Denver 27
Phoenix 27
Amsterdam 25
Haikou 25
Hangzhou 25
Istanbul 25
Johannesburg 25
Taizhou 25
Campinas 24
Poplar 24
Washington 24
Chennai 23
Manaus 23
Manchester 23
Nanchang 23
Toronto 23
Düsseldorf 22
Genoa 22
Orem 22
Atlanta 21
Boston 21
Goiânia 20
Totale 19.154
Nome #
State-Trait Anger Expression Inventory (STAXI) e Defense Mechanisms Inventory (DMI): i limiti di un questionario di autovalutazione 414
Alessitimia, emozioni negative e comportamento sessuale 411
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 367
Fattori di vulnerabilità psicosociale nella depressione postpartum 307
Fear and anxiety managing methods during dental treatments: a systematic review of recent data 238
Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis 218
Il Burnout e l'emozione rabbia. 204
Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn 192
JUVENILE CRIMINALITY AND EXECUTIVE COGNITIVE FUNCTIONING IN AN ITALIAN SAMPLE OF LATE-ONSET ADOLESCENT DELINQUENTS 191
Trattamento con agomelatina in soggetti affetti da fibromialgia: effetti sulla fenomenica depressiva, ansiosa e algica 188
Frazione polifenolica del bergamotto per il trattamento della sindrome metabolica nella schizofrenia: uno studio pilota [Bergamot polyphenolic fraction for the treatment of metabolic syndrome in schizophrenia: A pilot study] 187
Carcinoma mammario e disturbo depressivo. 184
Depressione e disturbi endocrini 181
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia. 180
Alessitimia, internet addiction disorder e mobile addiction in un campione di adolescenti 179
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 174
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders. 173
Indagine statistico-epidemiologica per l’analisi dei rischi dipsicopatologia in giovani affetti da diabete mellito di tipo 1 171
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 171
Valutazione dell’umore e della personalità in un campione di forti fumatori 165
Affective temperament traits and age-predicted recreational cannabis use in medical students: A cross-sectional study 161
Association between burnout and anger in oncology versus opthalmology health care professionals 160
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 159
Academic stress disrupts cortical plasticity in graduate students 159
Adolescenti: rabbia, sofferenza psicosomatica e tempo libero. 156
CORRELATION ANALYSIS BETWEEN PERSONALITY AND RESILIENCE IN NON CLINICAL SUBJECTS. 156
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 155
The inner muses: How affective temperament traits, gender and age predict film genre preference 155
Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study 154
Augmentation con Aripiprazolo vs. placebo nel disturbo ossessivo compulsivo con sintomatologia residua in trattamento stabilizzato con SSRI 154
Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome 152
Alexithymia, Negative Emotions, and Sexual Behavior in Heterosexual University Students from Italy 151
Extrasensory perception experiences and childhood trauma: A rorschach investigation 151
Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study 150
Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers. 150
Adult attention deficit/ hyperactivity disorder and borderline personality disorder 149
Defense mechanisms in hemodialysis-dependent patients 149
Depression, anxiety and anger in subtypes of irritable bowel syndrome patients 148
Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls. 148
Psychopharmacotherapy in pregnancy and breastfeeding 147
Exploring the effect of adaptogenic Rhodiola Rosea extract on neuroplasticity in humans 147
Comportamento sessuale ed immaginario erotico in donne tossicodipendenti. 146
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 146
Anger and Adolescence: A Psychometric Investigation on a Sample of Italian High School Students 145
STRESS LAVORO CORRELATO NEI MEDICI DI CONTINUITÀ ASSISTENZIALE. 142
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study 140
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 140
Comparation of levels of anxiety and depression in patients with autommune and chronic-degenerative rheumatic: preliminary data 140
Anger in health, benign breast disease and breast cancer: a prospective case-control study. 140
Grief and the new DSM-5 clinical category: A narrative review of the literature. 139
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. 138
Cannabis and Sexual Behavior 138
The wounds of childhood: Early trauma subtypes, salience and hyperarousal in a sample of adult psychiatric patients 136
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 136
Adolescence, Adulthood and Self-Perceived Halitosis: A Role of Psychological Factors 136
SUBTHRESHOLD PSYCHIATRIC SYMPTOMS AND POST-PARTUM MOOD DISORDERS 135
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 135
Neurobiological and Psychopathological mechanisms underlying addiction-like behaviors: an overview and thematic synthesis 135
Correlation Between Anger and Burnout in the Oncology Staff. 132
Funzioni neuropsicologiche e dimensioni psicopatologiche (positiva, negativa e disorganizzata) della schizofrenia. 131
Temperamento e alessitimia in un campione di soggetti antisociali con condotte di abuso. 131
IL-33 in Mental Disorders 131
Sleep Quality, Perceived Stress, and Caffeinated Drinks Intake in Psychiatry Residents: A Cross-Sectional Study 130
Inside-out: the role of anger experience and expression in the development of postpartum mood disorders 130
Donepezil adjunctive treatment to clozapine for cognitive impairment in schizophrenia 129
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 129
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 129
The relationship between sexual behavior and internet addiction severity in a sample of heterosexual university students from Italy. 129
Executive functions and basic symptoms in adolescent antisocial behavior: A cross-sectional study on an Italian sample of late-onset offenders. 128
Metabolic outcomes of Red yeast rice administration in patients treated with second-generation antipsychotics 128
“Comment on: Psychopathology and female detention at the “Pagliarelli” jail of Palermo: preliminary results.” 127
The role of alexithymia factors in adults with autism spectrum disorder: An explorative study 126
Psycho-Neuro-Endocrine-Immune System (PNEI) Involvement as Prognostic Marker in Breast Cancer Patients at 10 Years of Follow Up 124
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder. 124
Personality traits predict a medical student preference to pursue a career in surgery 124
Esplorazione neuropsicologica del lobo prefrontale nel disturbo schizofrenico 122
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 122
Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia 122
Complicated grief: A systematic review of the last 20 years 121
Personality traits and emotional patterns in irritable bowel Syndrome 121
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 120
Interazione farmacocinetica tra mirtazapina e clozapina in pazienti schizofrenici. 120
Attentional and mnestic resistance to interference and the positive, negative and disorganization dimensions of schizophrenia: a correlation study 120
LA VULNERABILITA' ALL'ESPERIENZA DEL TRAGICO 120
Meccanismi di difesa (D.M.I.) e temperamento (T.C.I.): studio di correlazione. 120
Antisocial personality disorder and subthresold symptomatology 120
Effetto di un trattamento con agomelatina sulle funzioni cognitive/esecutive di un campione di soggetti affetti da fibromialgia 120
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 120
Does personality matter? Temperament and character dimensions in panic subtypes 120
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 119
Aripiprazole Plus Topiramate in Opioid-dependent Patients with Schizoaffective Disorder: An 8-week, Open-label, Uncontrolled, Preliminary Study 119
Lifetime Psychiatric Comorbidity and Diagnostic Trajectories in an Italian Psychiatric Sample 119
Effetti comportamentali dell‘assunzione di L-Dopa in volontari sani. 118
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 118
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 117
Emotional profiles and psychopathology in severely obese patients: a psychological preoperative evaluation in bariatric surgery 117
Focus on Disruptive Mood Dysregulation Disorder: A review of the literature 117
Clinical, autoimmune, and psychiatric parameters correlate with sleep disturbance in patients with systemic sclerosis and rheumatoid arthritis 117
Body Image and Obese Identity in Bariatric Patients. Psychological factors and clinical management 117
EW0245 Cognitive outcomes of Bergamot Polyphenolic Fraction (BPF) supplementation in schizophrenia: Preliminary data 116
Totale 15.237
Categoria #
all - tutte 113.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021976 0 0 0 0 0 225 95 185 94 176 102 99
2021/20222.247 31 253 37 71 84 26 107 96 107 482 262 691
2022/20235.636 395 510 248 374 544 535 64 297 2.378 58 180 53
2023/20242.018 133 266 161 211 172 350 95 86 58 155 109 222
2024/20256.973 163 131 223 452 368 300 144 1.284 1.682 402 670 1.154
2025/202610.067 1.030 1.203 1.477 1.218 1.529 3.610 0 0 0 0 0 0
Totale 32.907